Search Results

You searched for : Takeda  

Biofourmis enters the Unicorn Club

Boston-based healthtech startup Biofourmis enters the Unicorn Club ($1 billion in valuation). The startup raised $300 million in its Series D funding round led ...
Apr 27

Chronic Disease Management with USA’s Biofourmis

CDC estimates that 6 in 10 American adults have 1 chronic disease whereas 4 in 10 suffer from 2 or more chronic diseases. Learn how ...
Feb 26

Biomarker startup Koneksa gains $45 million

Digital biomarker startup Koneksa has raised $45 million in their Series C funding round....
Feb 08

Wave Life Sciences and Takeda Amend CNS Collaboration

...
Oct 20

Takeda to commercialize Hunter Syndrome Therapy through collaboration with JCR Pharmaceuticals

Latest pharma news update...
Oct 04

Japan suspends use of about 1.63 million doses of Moderna vaccine due to contamination

Japan covid news update...
Aug 28

The liver performs 500 functions at the same time and is like the supercomputer of the body, says Dr. Vikram Raut

Dr. Vikram Raut Senior Consultant and Lead Liver Transplant Surgeon explains the signs and symptoms of liver disease and guides how to take care of ...
May 01

Takeda acquires Maverick Therapeutics for around $ 525 million benefit

Takeover to advance T-Cell Activator Solid Tumor Treatments and expand new Cancer Immunotherapy Portfolio...
Mar 13

Crescendo Biologics expands its ongoing collaboration with Takeda

This collaboration will help Crescendo’s proprietary transgenic platform and engineering expertise are being used to build Humabody-based therapeutics against certain targets selected by ...
Dec 11

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-...
Dec 04

Takeda completes sale of select OTC and non-core assets to Celltrion in Asia Pacific

Takeda Pharmaceutical Company Limited completes its previously-announced sale of a portfolio of select products to Celltrion Inc...
Dec 01

Bio and Pharma Integrates 2020: Live Online 16 & 17 November 2020

The digital networking space offers real-time, face-to-face engagement, which maximises chance encounters with other attendees...
Nov 12

Fast Track designation facilitates development of new therapies that treat serious conditions and fulfill unmet needs for patients

LogicBio Therapeutics Receives FDA Fast Track Designation for LB-001 for the Treatment of Methylmalonic Acidemia (MMA) ...
Nov 04

Takeda collaborates with Moderna to supply COVID-19 vaccine in Japan

Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan ...
Oct 29

Takeda accelerates digital transformation with Accenture and AWS

Collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future ...
Oct 13

Takeda Pharmaceutical has built new cell drug manufacturing facility for R & D

Takeda establishes new cell drug manufacturing facility for research and development to support expansion of next-generation clinical programs ...
Sep 19

Europe’s largest initiative launches to accelerate therapy development for COVID-19 and future Coronavirus threats

CARE aims to create effective therapies with a positive safety profile for the COVID-19 pandemic and develop new drugs and antibodies specially designed to ...
Aug 19

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization...
Aug 18

Novavax and Takeda Announce collaboration for Novavax’ COVID-19 vaccine candidate in Japan

Novavax partners with Takeda for manufacturing and marketing covid vaccine in Japan...
Aug 08

U.S. FDA approves Takeda’s ALUNBRIG for lung cancer patients

U.S. FDA Approves Takeda’s ALUNBRIG (brigatinib) as a first-line treatment option for patients diagnosed with rare and serious form of lung cancer ...
May 23

Takeda Announces Financial Results for Past Year

Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum ...
May 14

EC approves subcutaneous formulation of Entyvio for maintenance therapy in adults with Crohn's disease or Ulcerative Colitis

...
May 08

Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for Up to Approximately $670M USD

Portfolio includes select OTC and prescription products and two manufacturing facilities ...
Apr 27

Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial

Multiple myeloma is a life-threatening rare blood cancer that arises from the plasma cells, a type of white blood cell that is made in ...
Mar 12

Roche Arthritis drug Actemra is being used to Combat COVID-19 in China.

Roche has donated $2 million worth of Actemra to China before the anti-inflammatory med was officially added to Chinese authorities COVID-19 treatment guidelines. ...
Mar 06

25 Matching result(s) found!

-Advertisements-




Trending Now

Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024